comprehensive -WSS

comprehensive

author：comprehensive 2025-10-01 18:03:47 - browse：238

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Where are patients getting their prescriptions for GLP

WSS

How the first Native Hawaiian psychiatrist helped diversify medicine

CDC overhauls leadership of center that led response to Covid

Genentech weighs delaying cancer therapy after drug pricing law

How the first Native Hawaiian psychiatrist helped diversify medicine

White House drug shortages task force keeps mum with Congress

Genentech weighs delaying cancer therapy after drug pricing law

focus

comprehensive

leisure time

Walensky prepares to leave CDC — and Congress — behind

Roche's accidental data boosts hopes for anti

Medicare proposal to cover medical devices draws a mixed reaction

Study: Spinal cord stimulation helps patients with paralysis walk again

Hepatitis C has a cure — but many Americans still lack access to it

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Newly revealed memo details efforts to keep Trump in power following election loss

Hepatitis C has a cure — but many Americans still lack access to it

Roche's accidental data boosts hopes for anti

hotspot

Kellogg’s is going to war over Mexico’s nutrition label rules

How the first Native Hawaiian psychiatrist helped diversify medicine

Pharma budget tightening trickles down to Doximity

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Abortion policy in the spotlight at Republican debate

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

leisure time

entertainment

hotspot

focus